HUP0001347A2 - Szintetikus HIV gag gének - Google Patents

Szintetikus HIV gag gének

Info

Publication number
HUP0001347A2
HUP0001347A2 HU0001347A HUP0001347A HUP0001347A2 HU P0001347 A2 HUP0001347 A2 HU P0001347A2 HU 0001347 A HU0001347 A HU 0001347A HU P0001347 A HUP0001347 A HU P0001347A HU P0001347 A2 HUP0001347 A2 HU P0001347A2
Authority
HU
Hungary
Prior art keywords
hiv
gag
immune responses
hiv gag
synthetic hiv
Prior art date
Application number
HU0001347A
Other languages
English (en)
Inventor
Mary-Ellen Davies
Daniel C. Freed
Margaret A. Liu
Helen C. Perry
John W. Shiver
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of HUP0001347A2 publication Critical patent/HUP0001347A2/hu

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A találmány tárgyát módősítőtt HIV-géneket és génfragmenteket kódőlószintetikűs DNS-mőlekűlák képezik. A szintetikűs mőlekűlákszekvenciája a tervezett gazdasejt által előnyben részesítettkődőnőkat tartalmaz. A találmány tárgyát képezik őlyan pőlinűkleőtidőkis, melyek in vivő gerincesbe jűttatva a gazdaszervezetben a kódőltfehérjék expresszióját indűkálják. A találmány szerinti mőlekűlákalkalmazhatók pőlinűkleőtid vakcinaként, amely antitestneűtralizálásőn és sejtközvetített imműnitásőn keresztül hatékőnyimműn-prőfilaxist biztősít HIV-fertőzéssel szemben. ŕ
HU0001347A 1997-03-12 1998-02-03 Szintetikus HIV gag gének HUP0001347A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9705040.5A GB9705040D0 (en) 1997-03-12 1997-03-12 Synthetic HIV GAG genes

Publications (1)

Publication Number Publication Date
HUP0001347A2 true HUP0001347A2 (hu) 2000-08-28

Family

ID=10809059

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001347A HUP0001347A2 (hu) 1997-03-12 1998-02-03 Szintetikus HIV gag gének

Country Status (4)

Country Link
EA (1) EA199900726A1 (hu)
GB (1) GB9705040D0 (hu)
HU (1) HUP0001347A2 (hu)
PT (1) PT969862E (hu)

Also Published As

Publication number Publication date
EA199900726A1 (ru) 2000-04-24
GB9705040D0 (en) 1997-04-30
PT969862E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
AU2234995A (en) Feline immunodeficiency virus vaccine
DK605987D0 (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
HK1024714A1 (en) Dumbbell expression constructs for gene therapy
WO2005034992A3 (en) Hiv vaccines based on env of multiple clades of hif
NZ505108A (en) Vaccine composition comprising E6 or E7 protein from HPV and CpG oligonucleotide
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
NZ331161A (en) Synthetic HIV genes encoding envelope (env) proteins
WO1995024485A3 (en) Coordinate in vivo gene expression
AU3636189A (en) Hiv-2 virus variants
HRP940668B1 (en) Recombinant dna and rna and products derived therefrom
EP0873049A4 (hu)
Sturm et al. On the systematics of the Archaeognatha (Insecta)
HU9800053D0 (en) Gene primers for the detection of hiv-1
AU2567888A (en) Hiv peptides and methods for detection of hiv
HUP0001347A2 (hu) Szintetikus HIV gag gének
NO983375L (no) Retroviral vektor og anvendelse derav i genterapi
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
GB2275928B (en) Compound comprising a nucleic acid and a radioactive moiety
AP2005A (en) Process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype C isolates, their genes and modifications and derivatives thereof.
Church Human immunodeficiency virus.
Leutwyler Gene therapy for HIV.
Wardley et al. Feline immunodeficiency virus vaccine
WO2003018776A3 (en) IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS
WO2000005347A3 (en) Hepatitis b culture system